Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.52 |
| ▸ | DRD2 | P14416 | 5/20 | 0.52 |
| ▸ | DRD3 | P35462 | 3/20 | 0.52 |
| ▸ | DRD4 | P21917 | 2/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.51 |
| ▸ | TP53 | P04637 | 2/20 | 0.51 |
| ▸ | RAB9A | P51151 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | HTR1A | P08908 | 3/20 | 0.51 |
| ▸ | HTR2B | P41595 | 3/20 | 0.51 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.50 |
| ▸ | MC4R | P32245 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9551700 | 0.87 | HRH2 (0.59) | HRH3KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL11041528 | 0.86 | SIGMAR1 (0.52) | SIGMAR1DRD2DRD3DRD4NPC1 | |
| SCHEMBL10527698 | 0.86 | HRH2 (0.61) | HRH3 | |
| SCHEMBL30597717 | 0.86 | HRH2 (0.61) | HRH3 | |
| SCHEMBL5288663 | 0.86 | HRH2 (0.61) | HRH3 | |
| SCHEMBL10689006 | 0.86 | HRH2 (0.61) | HRH3 | |
| SCHEMBL10679839 | 0.86 | HRH2 (0.61) | HRH3 | |
| SCHEMBL25108942 | 0.85 | NPC1 (0.71) | SIGMAR1DRD2NPC1TP53RAB9A | |
| SCHEMBL22793926 | 0.85 | NPC1 (0.71) | SIGMAR1DRD2NPC1TP53RAB9A | |
| SCHEMBL24514671 | 0.85 | NPC1 (0.71) | SIGMAR1DRD2NPC1TP53RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0641789-B1 | BENZOTHIADIAZINE DERIVATIVE | TAIHO PHARMACEUTICAL CO LTD (JP) | 1997-12-03 | — | — | EP | disclosed |
| US-5401739-A | Benzothiadiazine derivatives | TAIHO PHARMACEUTICAL CO. LTD. (JP) | 1995-03-28 | — | — | US | disclosed |
| EP-0641789-A1 | BENZOTHIADIAZINE DERIVATIVE | TAIHO PHARMACEUTICAL COMPANY LIMITED (JP) | 1995-03-08 | — | — | EP | disclosed |
| US-4788184-A | Substituted 3-cyclobutene-1,2-diones as anti-ulcer agents | BRISTOL-MYERS COMPANY (US) | 1988-11-29 | — | — | US | disclosed |
| US-4772704-A | ANTIULCER AGENTS | BRISTOL-MYERS COMPANY (US) | 1988-09-20 | — | — | US | disclosed |
| US-4727081-A | ANTIULCER AGENTS | LUDWIG HEUMANN & CO. GMBH (DE) | 1988-02-23 | — | — | US | disclosed |
| EP-0040696-B1 | AMINOTHIADIAZOLES AS GASTRIC SECRETION INHIBITORS | MERCK & CO. INC. (US) | 1986-08-27 | — | — | EP | disclosed |
| US-4607105-A | FOR 1-(SUBSTITUTED AMINO)-2-(AMINO OR SUBSTITUTED) DERIVATIVES; HISTAMINE H2-ANTAGONISTS | BRISTOL-MYERS COMPANY (US) | 1986-08-19 | — | — | US | disclosed |
| EP-0180754-A2 | 3,4-Diazole derivatives, process for their preparation and medicines containing these compounds | LUDWIG HEUMANN & CO GMBH (DE) | 1986-05-14 | — | — | EP | disclosed |
| US-4546188-A | USEFUL IN TREATMENT OF PEPTIC ULCERS | BRISTOL-MYERS COMPANY (US) | 1985-10-08 | — | — | US | disclosed |
| US-4471122-A | Thiadiazole histamine H2 -antagonists | BRISTOL-MYERS COMPANY (US) | 1984-09-11 | — | — | US | disclosed |
| EP-0103503-A2 | N-substituted amides, their salts, process for their preparation and pharmaceutical compositions containing them | SANOFI S.A. (FR) | 1984-03-21 | — | — | EP | disclosed |
| EP-0101380-A2 | N-substituted nicotinamide-1-oxide, its salts, process for their preparation and pharmaceutical compositions containing them | SANOFI S.A. (FR) | 1984-02-22 | — | — | EP | disclosed |
| EP-0099122-A2 | Compositions comprising pepstatin and an histamine H2-receptor antagonist having an enhanced antiulcer activity | Bristol-Myers Company (US) | 1984-01-25 | — | — | EP | disclosed |
| EP-0099121-A2 | Pharmaceutical compositions | Bristol-Myers Company (US) | 1984-01-25 | — | — | EP | disclosed |
| US-4394508-A | ANTIULCER AND ANTISECRETORY AGENTS; HISTAMINE ANTAGONIST | BRISTOL-MYERS COMPANY (US) | 1983-07-19 | — | — | US | disclosed |
| US-4380639-A | ANTIULCER AND ANTISECRETORY AGENTS | BRISTOL-MYERS COMPANY (US) | 1983-04-19 | — | — | US | disclosed |
| US-4380638-A | ANTIULCER AND ANTISECRETORY AGENTS; DERIVATIVES OF 3-AMINO-4-HET-A | BRISTOL-MYERS COMPANY (US) | 1983-04-19 | — | — | US | disclosed |
| US-4374248-A | ANTIHISTAMINES, ANTIULCER | BRISTOL-MYERS COMPANY (US) | 1983-02-15 | — | — | US | disclosed |
| EP-0040696-A2 | Aminothiadiazoles as gastric secretion inhibitors | MERCK & CO. INC. (US) | 1981-12-02 | — | — | EP | disclosed |